Clare Harris
0000-0002-8233-7509
University of Southampton
9 papers found
Refreshing results…
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS)
P589 Real-world data on upadacitinib in the treatment of inflammatory bowel disease: safe and highly effective with extremely positive patient feedback
Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study
Impact of direct-access IBD physician delivered endoscopy on clinical outcomes: a pre-implementation and post-implementation study
Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS]
JAK1 inhibition and inflammatory bowel disease
Management of Crohn’s disease in an immunosuppressed COVID-19-positive patient: safety-driven prioritisation of nutritional therapy as a bridge to restarting immunosuppression
IBD reference and biosimilar adalimumab CroSS over study (iBaSS): design considerations and methodology
IBD Biosimilar to Biosimilar Infliximab Switching Study: preliminary results
Missing publications? Search for publications with a matching author name.